Cargando…

Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma

We aimed to create a mitophagy-related risk model via data mining of gene expression profiles to predict prognosis in uveal melanoma (UM) and develop a novel method for improving the prediction of clinical outcomes. Together with clinical information, RNA-seq and microarray data were gathered from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yanhua, Liu, Jingying, Fan, Huimin, Liu, Kangcheng, Zou, Hua, You, Zhipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760814/
https://www.ncbi.nlm.nih.gov/pubmed/36544483
http://dx.doi.org/10.3389/fgene.2022.1050341
_version_ 1784852564395687936
author Cheng, Yanhua
Liu, Jingying
Fan, Huimin
Liu, Kangcheng
Zou, Hua
You, Zhipeng
author_facet Cheng, Yanhua
Liu, Jingying
Fan, Huimin
Liu, Kangcheng
Zou, Hua
You, Zhipeng
author_sort Cheng, Yanhua
collection PubMed
description We aimed to create a mitophagy-related risk model via data mining of gene expression profiles to predict prognosis in uveal melanoma (UM) and develop a novel method for improving the prediction of clinical outcomes. Together with clinical information, RNA-seq and microarray data were gathered from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. ConsensusClusterPlus was used to detect mitophagy-related subgroups. The genes involved with mitophagy, and the UM prognosis were discovered using univariate Cox regression analysis. In an outside population, a mitophagy risk sign was constructed and verified using least absolute shrinkage and selection operator (LASSO) regression. Data from both survival studies and receiver operating characteristic (ROC) curve analyses were used to evaluate model performance, a bootstrap method was used test the model. Functional enrichment and immune infiltration were examined. A risk model was developed using six mitophagy-related genes (ATG12, CSNK2B, MTERF3, TOMM5, TOMM40, and TOMM70), and patients with UM were divided into low- and high-risk subgroups. Patients in the high-risk group had a lower chance of living longer than those in the low-risk group (p < 0.001). The ROC test indicated the accuracy of the signature. Moreover, prognostic nomograms and calibration plots, which included mitophagy signals, were produced with high predictive performance, and the risk model was strongly associated with the control of immune infiltration. Furthermore, functional enrichment analysis demonstrated that several mitophagy subtypes may be implicated in cancer, mitochondrial metabolism, and immunological control signaling pathways. The mitophagy-related risk model we developed may be used to anticipate the clinical outcomes of UM and highlight the involvement of mitophagy-related genes as prospective therapeutic options in UM. Furthermore, our study emphasizes the essential role of mitophagy in UM.
format Online
Article
Text
id pubmed-9760814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97608142022-12-20 Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma Cheng, Yanhua Liu, Jingying Fan, Huimin Liu, Kangcheng Zou, Hua You, Zhipeng Front Genet Genetics We aimed to create a mitophagy-related risk model via data mining of gene expression profiles to predict prognosis in uveal melanoma (UM) and develop a novel method for improving the prediction of clinical outcomes. Together with clinical information, RNA-seq and microarray data were gathered from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. ConsensusClusterPlus was used to detect mitophagy-related subgroups. The genes involved with mitophagy, and the UM prognosis were discovered using univariate Cox regression analysis. In an outside population, a mitophagy risk sign was constructed and verified using least absolute shrinkage and selection operator (LASSO) regression. Data from both survival studies and receiver operating characteristic (ROC) curve analyses were used to evaluate model performance, a bootstrap method was used test the model. Functional enrichment and immune infiltration were examined. A risk model was developed using six mitophagy-related genes (ATG12, CSNK2B, MTERF3, TOMM5, TOMM40, and TOMM70), and patients with UM were divided into low- and high-risk subgroups. Patients in the high-risk group had a lower chance of living longer than those in the low-risk group (p < 0.001). The ROC test indicated the accuracy of the signature. Moreover, prognostic nomograms and calibration plots, which included mitophagy signals, were produced with high predictive performance, and the risk model was strongly associated with the control of immune infiltration. Furthermore, functional enrichment analysis demonstrated that several mitophagy subtypes may be implicated in cancer, mitochondrial metabolism, and immunological control signaling pathways. The mitophagy-related risk model we developed may be used to anticipate the clinical outcomes of UM and highlight the involvement of mitophagy-related genes as prospective therapeutic options in UM. Furthermore, our study emphasizes the essential role of mitophagy in UM. Frontiers Media S.A. 2022-12-05 /pmc/articles/PMC9760814/ /pubmed/36544483 http://dx.doi.org/10.3389/fgene.2022.1050341 Text en Copyright © 2022 Cheng, Liu, Fan, Liu, Zou and You. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Cheng, Yanhua
Liu, Jingying
Fan, Huimin
Liu, Kangcheng
Zou, Hua
You, Zhipeng
Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
title Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
title_full Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
title_fullStr Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
title_full_unstemmed Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
title_short Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
title_sort integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760814/
https://www.ncbi.nlm.nih.gov/pubmed/36544483
http://dx.doi.org/10.3389/fgene.2022.1050341
work_keys_str_mv AT chengyanhua integrativeanalysesofamitophagyrelatedgenesignatureforpredictingprognosisinpatientswithuvealmelanoma
AT liujingying integrativeanalysesofamitophagyrelatedgenesignatureforpredictingprognosisinpatientswithuvealmelanoma
AT fanhuimin integrativeanalysesofamitophagyrelatedgenesignatureforpredictingprognosisinpatientswithuvealmelanoma
AT liukangcheng integrativeanalysesofamitophagyrelatedgenesignatureforpredictingprognosisinpatientswithuvealmelanoma
AT zouhua integrativeanalysesofamitophagyrelatedgenesignatureforpredictingprognosisinpatientswithuvealmelanoma
AT youzhipeng integrativeanalysesofamitophagyrelatedgenesignatureforpredictingprognosisinpatientswithuvealmelanoma